Markers of risk in young offspring with paternal history of myocardial infarction

scientific article published on 01 June 2003

Markers of risk in young offspring with paternal history of myocardial infarction is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0167-5273(02)00480-1
P698PubMed publication ID12767554

P2093author name stringThomas K Makris
Antonios N Hatzizacharias
Panagiota G Krespi
Caterina G Tsoukala
Emmanuel V Chronakis
John S Vythoulkas
Kouli Maria
Vassilios V Votteas
P2860cites workWeight-reducing effects of the plasma protein encoded by the obese geneQ29617934
Plasminogen activator inhibitor in the blood of patients with coronary artery diseaseQ34490676
Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosisQ37374639
High plasma immunoreactive leptin level in essential hypertensionQ38341667
Serum leptin levels are independently correlated with two measures of HDL.Q38344105
Role of the contact system in fibrinolysisQ39594111
Family history of coronary heart disease: is it an independent risk factor?Q39738095
Structural changes accompanying enzymatic activation of human Hageman factorQ40368436
Immune and inflammatory mechanisms in the development of atherosclerosisQ40872807
Coagulation and fibrinolytic factors in normotensive hypertension-prone men.Q40940610
Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic diseaseQ41673431
Hyperleptinaemia: the missing link in the, metabolic syndrome?Q50964327
Relation of risk factor levels in young adulthood to parental history of disease. The CARDIA study.Q51609375
Fibrinogen and risk of cardiovascular disease. The Framingham Study.Q52588834
Anticardiolipin antibodies in unselected autoimmune rheumatic disease patientsQ68826686
Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery diseaseQ69187061
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart StudyQ69886150
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarctionQ69973450
Fibrinogen as a risk factor for stroke and myocardial infarctionQ71438059
A need for standardization of the anti-endothelial-cell antibody testQ71711323
Genetic susceptibility to death from coronary heart disease in a study of twinsQ72290929
Haemostatic function and cardiovascular death: early results of a prospective studyQ72423400
Elevated plasma immunoreactive leptin levels preexist in healthy offspring of patients with essential hypertensionQ73128347
Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosisQ77697679
Genetic epidemiologyQ93853519
P433issue2-3
P407language of work or nameEnglishQ1860
P921main subjectmyocardial infarctionQ12152
P304page(s)287-293
P577publication date2003-06-01
P1433published inInternational Journal of CardiologyQ2357863
P1476titleMarkers of risk in young offspring with paternal history of myocardial infarction
P478volume89

Reverse relations

cites work (P2860)
Q36649341Better prognosis in overweight/obese coronary heart disease patients with high plasma levels of leptin
Q37198354Leptin and cardiovascular disease: response to therapeutic interventions
Q36903856Leptin as an important link between obesity and cardiovascular risk factors in men with acute myocardial infarction
Q79822450One-month therapy with simvastatin restores endothelial function in hypercholesterolemic children and adolescents

Search more.